STU 3 Ballot

This page is part of the FHIR Specification (v1.6.0: STU 3 Ballot 4). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3

V2-0292.cs.xml

Raw XML (canonical form)

FHIR Value set/code system definition for HL7 v2 table 0292 ( Vaccines Administered (code = CVX) (parenteral, un)

<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="v2-0292"/>
  <meta>
    <profile value="http://hl7.org/fhir/StructureDefinition/codesystem-shareable-definition"/>
  </meta>
  <text>
    <status value="additional"/>
    <div xmlns="http://www.w3.org/1999/xhtml">
      <p>Vaccines Administered (code = CVX) (parenteral, un</p>

      <table class="grid">
        <tr>
          <td>
            <b>Code</b>
          </td>
          <td>
            <b>Description</b>
          </td>
          <td>
            <b>Nederlands (Dutch)</b>
          </td>
          <td>
            <b>Comment</b>
          </td>
          <td>
            <b>Version</b>
          </td>
        </tr>
        <tr>
          <td>01
            <a name="01"> </a>
          </td>
          <td>DTP</td>
          <td>DKT - difterie-kinkhoest-tetanus</td>
          <td>diphtheria, tetanus toxoids and pertussis vaccine</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>02
            <a name="02"> </a>
          </td>
          <td>OPV</td>
          <td>OPV</td>
          <td>poliovirus vaccine, live, oral</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>03
            <a name="03"> </a>
          </td>
          <td>MMR</td>
          <td>BMR - bof, mazelen, rodehond</td>
          <td>measles, mumps and rubella virus vaccine</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>04
            <a name="04"> </a>
          </td>
          <td>M/R</td>
          <td>M/R</td>
          <td>measles and rubella virus vaccine</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>05
            <a name="05"> </a>
          </td>
          <td>measles</td>
          <td>mazelen</td>
          <td>measles virus vaccine</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>06
            <a name="06"> </a>
          </td>
          <td>rubella</td>
          <td>rodehond</td>
          <td>rubella virus vaccine</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>07
            <a name="07"> </a>
          </td>
          <td>mumps</td>
          <td>bof</td>
          <td>mumps virus vaccine</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>08
            <a name="08"> </a>
          </td>
          <td>Hep B, adolescent or pediatric</td>
          <td>Hep B, adolescent of pediatrie</td>
          <td>hepatitis B vaccine, pediatric or pediatric/adolescent dosage</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>09
            <a name="09"> </a>
          </td>
          <td>Td (adult)</td>
          <td>DT - difterie en tetanus (volwassene)</td>
          <td>tetanus and diphtheria toxoids, adsorbed for adult use</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>10
            <a name="10"> </a>
          </td>
          <td>IPV</td>
          <td>IPV</td>
          <td>poliovirus vaccine, inactivated</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>100
            <a name="100"> </a>
          </td>
          <td>pneumococcal conjugate</td>
          <td>pneumokokken conjugaat</td>
          <td>pneumococcal conjugate vaccine, polyvalent</td>
          <td>added v2.4</td>
        </tr>
        <tr>
          <td>101
            <a name="101"> </a>
          </td>
          <td>typhoid, ViCPs</td>
          <td>tyfus, ViCPs</td>
          <td>typhoid Vi capsular polysaccharide vaccine</td>
          <td>added v2.4</td>
        </tr>
        <tr>
          <td>102
            <a name="102"> </a>
          </td>
          <td>DTP-Hib-Hep B</td>
          <td>DKT-Hib-Hep B</td>
          <td>DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine</td>
          <td>added v2.5</td>
        </tr>
        <tr>
          <td>103
            <a name="103"> </a>
          </td>
          <td>meningococcal C conjugate</td>
          <td>meningokokken C conjugaat</td>
          <td>meningococcal C conjugate vaccine</td>
          <td>added v2.5</td>
        </tr>
        <tr>
          <td>104
            <a name="104"> </a>
          </td>
          <td>Hep A-Hep B</td>
          <td>Hep A-Hep B</td>
          <td>hepatitis A and hepatitis B vaccine</td>
          <td>added v2.5</td>
        </tr>
        <tr>
          <td>105
            <a name="105"> </a>
          </td>
          <td>vaccinia (smallpox) diluted</td>
          <td>vaccinia (pokken) verzwakt</td>
          <td>vaccinia (smallpox) vaccine, diluted</td>
          <td>added v2.5</td>
        </tr>
        <tr>
          <td>106
            <a name="106"> </a>
          </td>
          <td>DTaP, 5 pertussis antigens6</td>
          <td>DaKT, 5 kinkhoest antigenen6</td>
          <td>diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens</td>
          <td>added v2.5</td>
        </tr>
        <tr>
          <td>107
            <a name="107"> </a>
          </td>
          <td>DTaP, NOS</td>
          <td>DaKT, niet anders gespecificeerd</td>
          <td>diphtheria, tetanus toxoids and acellular pertussis vaccine, NOS</td>
          <td>added v2.5</td>
        </tr>
        <tr>
          <td>108
            <a name="108"> </a>
          </td>
          <td>meningococcal, NOS</td>
          <td>meningokokken, niet anders gespecificeerd</td>
          <td>meningococcal vaccine, NOS</td>
          <td>added v2.5</td>
        </tr>
        <tr>
          <td>109
            <a name="109"> </a>
          </td>
          <td>pneumococcal, NOS</td>
          <td>pneumokokken, niet anders gespecificeerd</td>
          <td>pneumococcal vaccine, NOS</td>
          <td>added v2.5</td>
        </tr>
        <tr>
          <td>11
            <a name="11"> </a>
          </td>
          <td>pertussis</td>
          <td>kinkhoest</td>
          <td>pertussis vaccine</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>110
            <a name="110"> </a>
          </td>
          <td>DTaP-Hep B-IPV</td>
          <td>DaKT-Hep B-IPV</td>
          <td>DTaP-hepatitis B and poliovirus vaccine</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>111
            <a name="111"> </a>
          </td>
          <td>influenza, live, intranasal</td>
          <td>influenza, levend, intranasaal</td>
          <td>influenza virus vaccine, live, attenuated, for intranasal use</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>112
            <a name="112"> </a>
          </td>
          <td>tetanus toxoid, NOS</td>
          <td>tetanus toxoïde, niet anders gespecificeerd</td>
          <td>tetanus toxoid, NOS</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>113
            <a name="113"> </a>
          </td>
          <td>Td (adult)</td>
          <td>DT - difterie en tetanus (volwassene)</td>
          <td>tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>114
            <a name="114"> </a>
          </td>
          <td>meningococcal A,C,Y,W-135 diphtheria conjugate</td>
          <td>meningokokken A,C,Y,W-135 difterie conjugaat</td>
          <td>meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine
               (MCV4)</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>115
            <a name="115"> </a>
          </td>
          <td>Tdap</td>
          <td>tetanus toxoïde, verminderde difterie toxoïde, en acellulaire kinkhoest</td>
          <td>tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>116
            <a name="116"> </a>
          </td>
          <td>rotavirus, pentavalent</td>
          <td>rotavirus, pentavalent</td>
          <td>rotavirus, live, pentavalent vaccine</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>117
            <a name="117"> </a>
          </td>
          <td>VZIG (IND)</td>
          <td>VZIG (IND)</td>
          <td>varicella zoster immune globulin (Investigational New Drug)</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>118
            <a name="118"> </a>
          </td>
          <td>HPV, bivalent</td>
          <td>HPV, bivalent</td>
          <td>human papilloma virus vaccine, bivalent</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>119
            <a name="119"> </a>
          </td>
          <td>rotavirus, monovalent</td>
          <td>rotavirus, monovalent</td>
          <td>rotavirus, live, monovalent vaccine</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>12
            <a name="12"> </a>
          </td>
          <td>diphtheria antitoxin</td>
          <td>difterie antitoxine</td>
          <td>diphtheria antitoxin</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>120
            <a name="120"> </a>
          </td>
          <td>DTaP-Hib-IPV</td>
          <td>DaKT-Hib-IPV</td>
          <td>diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type
               b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>121
            <a name="121"> </a>
          </td>
          <td>zoster</td>
          <td>gordelroos</td>
          <td>zoster vaccine, live</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>122
            <a name="122"> </a>
          </td>
          <td>rotavirus, NOS1</td>
          <td>rotavirus, niet anders gespecificeerd1</td>
          <td>rotavirus vaccine, NOS</td>
          <td>added v2.6</td>
        </tr>
        <tr>
          <td>13
            <a name="13"> </a>
          </td>
          <td>TIG</td>
          <td>TIG</td>
          <td>tetanus immune globulin</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>14
            <a name="14"> </a>
          </td>
          <td>IG, NOS</td>
          <td>IG, niet anders gespecificeerd</td>
          <td>immune globulin, NOS</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>15
            <a name="15"> </a>
          </td>
          <td>influenza, split (incl. purified surface antigen)</td>
          <td>influenza, gesplitst (incl. gezuiverd oppervlakte antigen)</td>
          <td>influenza virus vaccine, split virus (incl. purified surface antigen)</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>16
            <a name="16"> </a>
          </td>
          <td>influenza, whole</td>
          <td>influenza, geheel</td>
          <td>influenza virus vaccine, whole virus</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>17
            <a name="17"> </a>
          </td>
          <td>Hib, NOS</td>
          <td>Hib, niet anders gespecificeerd</td>
          <td>Haemophilus influenzae type b vaccine, conjugate NOS</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>18
            <a name="18"> </a>
          </td>
          <td>rabies, intramuscular injection</td>
          <td>hondsdolheid, intramusculaire injectie</td>
          <td>rabies vaccine, for intramuscular injection</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>19
            <a name="19"> </a>
          </td>
          <td>BCG</td>
          <td>BCG</td>
          <td>Bacillus Calmette-Guerin vaccine</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>20
            <a name="20"> </a>
          </td>
          <td>DTaP</td>
          <td>DaKT -difterie-acellulaire kinkhoest-tetanus</td>
          <td>diphtheria, tetanus toxoids and acellular pertussis vaccine</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>21
            <a name="21"> </a>
          </td>
          <td>varicella</td>
          <td>varicella</td>
          <td>varicella virus vaccine</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>22
            <a name="22"> </a>
          </td>
          <td>DTP-Hib</td>
          <td>DKT-Hib</td>
          <td>DTP-Haemophilus influenzae type b conjugate vaccine</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>23
            <a name="23"> </a>
          </td>
          <td>plague</td>
          <td>pest</td>
          <td>plague vaccine</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>24
            <a name="24"> </a>
          </td>
          <td>anthrax</td>
          <td>miltvuur</td>
          <td>anthrax vaccine</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>25
            <a name="25"> </a>
          </td>
          <td>typhoid, oral</td>
          <td>tyfus, oral</td>
          <td>typhoid vaccine, live, oral</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>26
            <a name="26"> </a>
          </td>
          <td>cholera</td>
          <td>cholera</td>
          <td>cholera vaccine</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>27
            <a name="27"> </a>
          </td>
          <td>botulinum antitoxin</td>
          <td>botulisme antitoxine</td>
          <td>botulinum antitoxin</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>28
            <a name="28"> </a>
          </td>
          <td>DT (pediatric)</td>
          <td>DT - difterie-tetanus (pediatrie)</td>
          <td>diphtheria and tetanus toxoids, adsorbed for pediatric use</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>29
            <a name="29"> </a>
          </td>
          <td>CMVIG</td>
          <td>CMVIG</td>
          <td>cytomegalovirus immune globulin, intravenous</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>30
            <a name="30"> </a>
          </td>
          <td>HBIG</td>
          <td>HBIG</td>
          <td>hepatitis B immune globulin</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>31
            <a name="31"> </a>
          </td>
          <td>Hep A, pediatric, NOS</td>
          <td>Hep A, pediatrie, niet anders gespecificeerd</td>
          <td>hepatitis A vaccine, pediatric dosage, NOS</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>32
            <a name="32"> </a>
          </td>
          <td>meningococcal</td>
          <td>meningokokken</td>
          <td>meningococcal polysaccharide vaccine (MPSV4)</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>33
            <a name="33"> </a>
          </td>
          <td>pneumococcal</td>
          <td>pneumokokken</td>
          <td>pneumococcal polysaccharide vaccine</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>34
            <a name="34"> </a>
          </td>
          <td>RIG</td>
          <td>hondsdolheid immunoglobuline</td>
          <td>rabies immune globulin</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>35
            <a name="35"> </a>
          </td>
          <td>tetanus toxoid</td>
          <td>tetanus toxoïde</td>
          <td>tetanus toxoid, adsorbed</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>36
            <a name="36"> </a>
          </td>
          <td>VZIG</td>
          <td>VZIG</td>
          <td>varicella zoster immune globulin</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>37
            <a name="37"> </a>
          </td>
          <td>yellow fever</td>
          <td>gele koorts</td>
          <td>yellow fever vaccine</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>38
            <a name="38"> </a>
          </td>
          <td>rubella/mumps</td>
          <td>rodehond/bof</td>
          <td>rubella and mumps virus vaccine</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>39
            <a name="39"> </a>
          </td>
          <td>Japanese encephalitis</td>
          <td>Japanse encefalitis</td>
          <td>Japanese encephalitis vaccine</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>40
            <a name="40"> </a>
          </td>
          <td>rabies, intradermal injection</td>
          <td>hondsdolheid, intradermale injectie</td>
          <td>rabies vaccine, for intradermal injection</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>41
            <a name="41"> </a>
          </td>
          <td>typhoid, parenteral</td>
          <td>tyfus, parenteraal</td>
          <td>typhoid vaccine, parenteral, other than acetone-killed, dried</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>42
            <a name="42"> </a>
          </td>
          <td>Hep B, adolescent/high risk infant2</td>
          <td>Hep B, adolescent/hoogrisico zuigeling2</td>
          <td>hepatitis B vaccine, adolescent/high risk infant dosage</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>43
            <a name="43"> </a>
          </td>
          <td>Hep B, adult4</td>
          <td>Hep B, volwassen4</td>
          <td>hepatitis B vaccine, adult dosage</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>44
            <a name="44"> </a>
          </td>
          <td>Hep B, dialysis</td>
          <td>Hep B, dialyse</td>
          <td>hepatitis B vaccine, dialysis patient dosage</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>45
            <a name="45"> </a>
          </td>
          <td>Hep B, NOS</td>
          <td>Hep B, niet anders gespecificeerd</td>
          <td>hepatitis B vaccine, NOS</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>46
            <a name="46"> </a>
          </td>
          <td>Hib (PRP-D)</td>
          <td>Hib (PRP-D)</td>
          <td>Haemophilus influenzae type b vaccine, PRP-D conjugate</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>47
            <a name="47"> </a>
          </td>
          <td>Hib (HbOC)</td>
          <td>Hib (HbOC)</td>
          <td>Haemophilus influenzae type b vaccine, HbOC conjugate</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>48
            <a name="48"> </a>
          </td>
          <td>Hib (PRP-T)</td>
          <td>Hib (PRP-T)</td>
          <td>Haemophilus influenzae type b vaccine, PRP-T conjugate</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>49
            <a name="49"> </a>
          </td>
          <td>Hib (PRP-OMP)</td>
          <td>Hib (PRP-OMP)</td>
          <td>Haemophilus influenzae type b vaccine, PRP-OMP conjugate</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>50
            <a name="50"> </a>
          </td>
          <td>DTaP-Hib</td>
          <td>DaKT-Hib</td>
          <td>DTaP-Haemophilus influenzae type b conjugate vaccine</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>51
            <a name="51"> </a>
          </td>
          <td>Hib-Hep B</td>
          <td>Hib-Hep B</td>
          <td>Haemophilus influenzae type b conjugate and Hepatitis B vaccine</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>52
            <a name="52"> </a>
          </td>
          <td>Hep A, adult</td>
          <td>Hep A, volwassene</td>
          <td>hepatitis A vaccine, adult dosage</td>
          <td>added v2.3</td>
        </tr>
        <tr>
          <td>53
            <a name="53"> </a>
          </td>
          <td>typhoid, parenteral, AKD (U.S. military)</td>
          <td>tyfus, parenteraal, AKD (Amerikaanse leger)</td>
          <td>typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>54
            <a name="54"> </a>
          </td>
          <td>adenovirus, type 4</td>
          <td>adenovirus, type 4</td>
          <td>adenovirus vaccine, type 4, live, oral</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>55
            <a name="55"> </a>
          </td>
          <td>adenovirus, type 7</td>
          <td>adenovirus, type 7</td>
          <td>adenovirus vaccine, type 7, live, oral</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>56
            <a name="56"> </a>
          </td>
          <td>dengue fever</td>
          <td>knokkelkoorts</td>
          <td>dengue fever vaccine</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>57
            <a name="57"> </a>
          </td>
          <td>hantavirus</td>
          <td>hantavirus</td>
          <td>hantavirus vaccine</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>58
            <a name="58"> </a>
          </td>
          <td>Hep C</td>
          <td>Hep C</td>
          <td>hepatitis C vaccine</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>59
            <a name="59"> </a>
          </td>
          <td>Hep E</td>
          <td>Hep E</td>
          <td>hepatitis E vaccine</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>60
            <a name="60"> </a>
          </td>
          <td>herpes simplex 2</td>
          <td>herpes simplex 2</td>
          <td>herpes simplex virus, type 2 vaccine</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>61
            <a name="61"> </a>
          </td>
          <td>HIV</td>
          <td>HIV</td>
          <td>human immunodeficiency virus vaccine</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>62
            <a name="62"> </a>
          </td>
          <td>HPV, quadrivalent</td>
          <td>HPV, quadrivalent</td>
          <td>human papilloma virus vaccine, quadrivalent</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>63
            <a name="63"> </a>
          </td>
          <td>Junin virus</td>
          <td>Junín virus</td>
          <td>Junin virus vaccine</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>64
            <a name="64"> </a>
          </td>
          <td>leishmaniasis</td>
          <td>leishmaniase</td>
          <td>leishmaniasis vaccine</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>65
            <a name="65"> </a>
          </td>
          <td>leprosy</td>
          <td>lepra</td>
          <td>leprosy vaccine</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>66
            <a name="66"> </a>
          </td>
          <td>Lyme disease</td>
          <td>ziekte van Lyme</td>
          <td>Lyme disease vaccine</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>67
            <a name="67"> </a>
          </td>
          <td>malaria</td>
          <td>malaria</td>
          <td>malaria vaccine</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>68
            <a name="68"> </a>
          </td>
          <td>melanoma</td>
          <td>melanoom</td>
          <td>melanoma vaccine</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>69
            <a name="69"> </a>
          </td>
          <td>parainfluenza-3</td>
          <td>parainfluenza-3</td>
          <td>parainfluenza-3 virus vaccine</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>70
            <a name="70"> </a>
          </td>
          <td>Q fever</td>
          <td>Q-koorts</td>
          <td>Q fever vaccine</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>71
            <a name="71"> </a>
          </td>
          <td>RSV-IGIV</td>
          <td>RSV-IGIV</td>
          <td>respiratory syncytial virus immune globulin, intravenous</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>72
            <a name="72"> </a>
          </td>
          <td>rheumatic fever</td>
          <td>reumatische koorts</td>
          <td>rheumatic fever vaccine</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>73
            <a name="73"> </a>
          </td>
          <td>Rift Valley fever</td>
          <td>Riftdalkoorts</td>
          <td>Rift Valley fever vaccine</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>74
            <a name="74"> </a>
          </td>
          <td>rotavirus, tetravalent</td>
          <td>rotavirus, tetravalent</td>
          <td>rotavirus, live, tetravalent vaccine</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>75
            <a name="75"> </a>
          </td>
          <td>vaccinia (smallpox)</td>
          <td>vaccinia (pokken)</td>
          <td>vaccinia (smallpox) vaccine</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>76
            <a name="76"> </a>
          </td>
          <td>Staphylococcus bacterio lysate</td>
          <td>Staphylococcus bacterio lysate</td>
          <td>Staphylococcus bacteriophage lysate</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>77
            <a name="77"> </a>
          </td>
          <td>tick-borne encephalitis</td>
          <td>frühsommer-meningoenzephalitis vaccin</td>
          <td>tick-borne encephalitis vaccine</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>78
            <a name="78"> </a>
          </td>
          <td>tularemia vaccine</td>
          <td>tularemia vaccin</td>
          <td>tularemia vaccine</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>79
            <a name="79"> </a>
          </td>
          <td>vaccinia immune globulin</td>
          <td>vaccinia immunoglobuline</td>
          <td>vaccinia immune globulin</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>80
            <a name="80"> </a>
          </td>
          <td>VEE, live</td>
          <td>VEE, levend</td>
          <td>Venezuelan equine encephalitis, live, attenuated</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>81
            <a name="81"> </a>
          </td>
          <td>VEE, inactivated</td>
          <td>VEE, inactief</td>
          <td>Venezuelan equine encephalitis, inactivated</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>82
            <a name="82"> </a>
          </td>
          <td>adenovirus, NOS1</td>
          <td>adenovirus, niet anders gespecificeerd1</td>
          <td>adenovirus vaccine, NOS</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>83
            <a name="83"> </a>
          </td>
          <td>Hep A, ped/adol, 2 dose</td>
          <td>Hep A, ped/adol, 2 dosis</td>
          <td>hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>84
            <a name="84"> </a>
          </td>
          <td>Hep A, ped/adol, 3 dose</td>
          <td>Hep A, ped/adol, 3 dosis</td>
          <td>hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>85
            <a name="85"> </a>
          </td>
          <td>Hep A, NOS</td>
          <td>Hep A, niet anders gespecificeerd</td>
          <td>hepatitis A vaccine, NOS</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>86
            <a name="86"> </a>
          </td>
          <td>IG</td>
          <td>IG</td>
          <td>immune globulin, intramuscular</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>87
            <a name="87"> </a>
          </td>
          <td>IGIV</td>
          <td>IGIV</td>
          <td>immune globulin, intravenous</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>88
            <a name="88"> </a>
          </td>
          <td>influenza, NOS</td>
          <td>influenza, niet anders gespecificeerd</td>
          <td>influenza virus vaccine, NOS</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>89
            <a name="89"> </a>
          </td>
          <td>polio, NOS</td>
          <td>polio, niet anders gespecificeerd</td>
          <td>poliovirus vaccine, NOS</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>90
            <a name="90"> </a>
          </td>
          <td>rabies, NOS</td>
          <td>hondsdolheid, niet anders gespecificeerd</td>
          <td>rabies vaccine, NOS</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>91
            <a name="91"> </a>
          </td>
          <td>typhoid, NOS</td>
          <td>tyfus, niet anders gespecificeerd</td>
          <td>typhoid vaccine, NOS</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>92
            <a name="92"> </a>
          </td>
          <td>VEE, NOS</td>
          <td>VEE, niet anders gespecificeerd</td>
          <td>Venezuelan equine encephalitis vaccine, NOS</td>
          <td>added v2.3.1</td>
        </tr>
        <tr>
          <td>93
            <a name="93"> </a>
          </td>
          <td>RSV-MAb</td>
          <td>RSV-MAb</td>
          <td>respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular</td>
          <td>added v2.4</td>
        </tr>
        <tr>
          <td>94
            <a name="94"> </a>
          </td>
          <td>MMRV</td>
          <td>BMRV - bof, mazelen, rodehond en varicella</td>
          <td>measles, mumps, rubella, and varicella virus vaccine</td>
          <td>added v2.4</td>
        </tr>
        <tr>
          <td>95
            <a name="95"> </a>
          </td>
          <td>TST-OT tine test</td>
          <td>TST-OT tine test</td>
          <td>tuberculin skin test; old tuberculin, multipuncture device</td>
          <td>added v2.4</td>
        </tr>
        <tr>
          <td>96
            <a name="96"> </a>
          </td>
          <td>TST-PPD intradermal</td>
          <td>TST-PPD intradermal</td>
          <td>tuberculin skin test; purified protein derivative solution, intradermal</td>
          <td>added v2.4</td>
        </tr>
        <tr>
          <td>97
            <a name="97"> </a>
          </td>
          <td>TST-PPD tine test</td>
          <td>TST-PPD tine test</td>
          <td>tuberculin skin test; purified protein derivative, multipuncture device</td>
          <td>added v2.4</td>
        </tr>
        <tr>
          <td>98
            <a name="98"> </a>
          </td>
          <td>TST, NOS</td>
          <td>TST, niet anders gespecificeerd</td>
          <td>tuberculin skin test; NOS</td>
          <td>added v2.4</td>
        </tr>
        <tr>
          <td>99
            <a name="99"> </a>
          </td>
          <td>RESERVED - do not use3</td>
          <td>GERESERVEERD - niet gebruiken3</td>
          <td>RESERVED - do not use</td>
          <td>added v2.4</td>
        </tr>
        <tr>
          <td>998
            <a name="998"> </a>
          </td>
          <td>no vaccine administered5</td>
          <td>geen vaccin toegediend5</td>
          <td>no vaccine administered</td>
          <td>added v2.5</td>
        </tr>
        <tr>
          <td>999
            <a name="999"> </a>
          </td>
          <td>unknown</td>
          <td>onbekend</td>
          <td>unknown vaccine or immune globulin</td>
          <td>added v2.4</td>
        </tr>
      </table>

    </div>
  </text>
  <url value="http://hl7.org/fhir/v2/0292"/>
  <identifier>
    <system value="urn:ietf:rfc:3986"/>
    <value value="urn:oid:2.16.840.1.133883.18.182"/>
  </identifier>
  <version value="2.8.2"/>
  <name value="v2 Vaccines Administered (code = CVX) (parenteral, un"/>
  <status value="active"/>
  <experimental value="true"/>
  <publisher value="HL7, Inc"/>
  <contact>
    <telecom>
      <system value="other"/>
      <value value="http://hl7.org"/>
    </telecom>
  </contact>
  <description value="FHIR Value set/code system definition for HL7 v2 table 0292 ( Vaccines Administered (code
     = CVX) (parenteral, un)"/>
  <caseSensitive value="false"/>
  <valueSet value="http://hl7.org/fhir/ValueSet/v2-0292"/>
  <content value="complete"/>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="diphtheria, tetanus toxoids and pertussis vaccine"/>
    </extension>
    <code value="01"/>
    <display value="DTP"/>
    <designation>
      <language value="nl"/>
      <value value="DKT - difterie-kinkhoest-tetanus"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="poliovirus vaccine, live, oral"/>
    </extension>
    <code value="02"/>
    <display value="OPV"/>
    <designation>
      <language value="nl"/>
      <value value="OPV"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="measles, mumps and rubella virus vaccine"/>
    </extension>
    <code value="03"/>
    <display value="MMR"/>
    <designation>
      <language value="nl"/>
      <value value="BMR - bof, mazelen, rodehond"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="measles and rubella virus vaccine"/>
    </extension>
    <code value="04"/>
    <display value="M/R"/>
    <designation>
      <language value="nl"/>
      <value value="M/R"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="measles virus vaccine"/>
    </extension>
    <code value="05"/>
    <display value="measles"/>
    <designation>
      <language value="nl"/>
      <value value="mazelen"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="rubella virus vaccine"/>
    </extension>
    <code value="06"/>
    <display value="rubella"/>
    <designation>
      <language value="nl"/>
      <value value="rodehond"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="mumps virus vaccine"/>
    </extension>
    <code value="07"/>
    <display value="mumps"/>
    <designation>
      <language value="nl"/>
      <value value="bof"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="hepatitis B vaccine, pediatric or pediatric/adolescent dosage"/>
    </extension>
    <code value="08"/>
    <display value="Hep B, adolescent or pediatric"/>
    <designation>
      <language value="nl"/>
      <value value="Hep B, adolescent of pediatrie"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="tetanus and diphtheria toxoids, adsorbed for adult use"/>
    </extension>
    <code value="09"/>
    <display value="Td (adult)"/>
    <designation>
      <language value="nl"/>
      <value value="DT - difterie en tetanus (volwassene)"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="poliovirus vaccine, inactivated"/>
    </extension>
    <code value="10"/>
    <display value="IPV"/>
    <designation>
      <language value="nl"/>
      <value value="IPV"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="pneumococcal conjugate vaccine, polyvalent"/>
    </extension>
    <code value="100"/>
    <display value="pneumococcal conjugate"/>
    <designation>
      <language value="nl"/>
      <value value="pneumokokken conjugaat"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="typhoid Vi capsular polysaccharide vaccine"/>
    </extension>
    <code value="101"/>
    <display value="typhoid, ViCPs"/>
    <designation>
      <language value="nl"/>
      <value value="tyfus, ViCPs"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine"/>
    </extension>
    <code value="102"/>
    <display value="DTP-Hib-Hep B"/>
    <designation>
      <language value="nl"/>
      <value value="DKT-Hib-Hep B"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="meningococcal C conjugate vaccine"/>
    </extension>
    <code value="103"/>
    <display value="meningococcal C conjugate"/>
    <designation>
      <language value="nl"/>
      <value value="meningokokken C conjugaat"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="hepatitis A and hepatitis B vaccine"/>
    </extension>
    <code value="104"/>
    <display value="Hep A-Hep B"/>
    <designation>
      <language value="nl"/>
      <value value="Hep A-Hep B"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="vaccinia (smallpox) vaccine, diluted"/>
    </extension>
    <code value="105"/>
    <display value="vaccinia (smallpox) diluted"/>
    <designation>
      <language value="nl"/>
      <value value="vaccinia (pokken) verzwakt"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens"/>
    </extension>
    <code value="106"/>
    <display value="DTaP, 5 pertussis antigens6"/>
    <designation>
      <language value="nl"/>
      <value value="DaKT, 5 kinkhoest antigenen6"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="diphtheria, tetanus toxoids and acellular pertussis vaccine, NOS"/>
    </extension>
    <code value="107"/>
    <display value="DTaP, NOS"/>
    <designation>
      <language value="nl"/>
      <value value="DaKT, niet anders gespecificeerd"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="meningococcal vaccine, NOS"/>
    </extension>
    <code value="108"/>
    <display value="meningococcal, NOS"/>
    <designation>
      <language value="nl"/>
      <value value="meningokokken, niet anders gespecificeerd"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="pneumococcal vaccine, NOS"/>
    </extension>
    <code value="109"/>
    <display value="pneumococcal, NOS"/>
    <designation>
      <language value="nl"/>
      <value value="pneumokokken, niet anders gespecificeerd"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="pertussis vaccine"/>
    </extension>
    <code value="11"/>
    <display value="pertussis"/>
    <designation>
      <language value="nl"/>
      <value value="kinkhoest"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="DTaP-hepatitis B and poliovirus vaccine"/>
    </extension>
    <code value="110"/>
    <display value="DTaP-Hep B-IPV"/>
    <designation>
      <language value="nl"/>
      <value value="DaKT-Hep B-IPV"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="influenza virus vaccine, live, attenuated, for intranasal use"/>
    </extension>
    <code value="111"/>
    <display value="influenza, live, intranasal"/>
    <designation>
      <language value="nl"/>
      <value value="influenza, levend, intranasaal"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="tetanus toxoid, NOS"/>
    </extension>
    <code value="112"/>
    <display value="tetanus toxoid, NOS"/>
    <designation>
      <language value="nl"/>
      <value value="tetanus toxoïde, niet anders gespecificeerd"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use"/>
    </extension>
    <code value="113"/>
    <display value="Td (adult)"/>
    <designation>
      <language value="nl"/>
      <value value="DT - difterie en tetanus (volwassene)"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine
         (MCV4)"/>
    </extension>
    <code value="114"/>
    <display value="meningococcal A,C,Y,W-135 diphtheria conjugate"/>
    <designation>
      <language value="nl"/>
      <value value="meningokokken A,C,Y,W-135 difterie conjugaat"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed"/>
    </extension>
    <code value="115"/>
    <display value="Tdap"/>
    <designation>
      <language value="nl"/>
      <value value="tetanus toxoïde, verminderde difterie toxoïde, en acellulaire kinkhoest"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="rotavirus, live, pentavalent vaccine"/>
    </extension>
    <code value="116"/>
    <display value="rotavirus, pentavalent"/>
    <designation>
      <language value="nl"/>
      <value value="rotavirus, pentavalent"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="varicella zoster immune globulin (Investigational New Drug)"/>
    </extension>
    <code value="117"/>
    <display value="VZIG (IND)"/>
    <designation>
      <language value="nl"/>
      <value value="VZIG (IND)"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="human papilloma virus vaccine, bivalent"/>
    </extension>
    <code value="118"/>
    <display value="HPV, bivalent"/>
    <designation>
      <language value="nl"/>
      <value value="HPV, bivalent"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="rotavirus, live, monovalent vaccine"/>
    </extension>
    <code value="119"/>
    <display value="rotavirus, monovalent"/>
    <designation>
      <language value="nl"/>
      <value value="rotavirus, monovalent"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="diphtheria antitoxin"/>
    </extension>
    <code value="12"/>
    <display value="diphtheria antitoxin"/>
    <designation>
      <language value="nl"/>
      <value value="difterie antitoxine"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type
         b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)"/>
    </extension>
    <code value="120"/>
    <display value="DTaP-Hib-IPV"/>
    <designation>
      <language value="nl"/>
      <value value="DaKT-Hib-IPV"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="zoster vaccine, live"/>
    </extension>
    <code value="121"/>
    <display value="zoster"/>
    <designation>
      <language value="nl"/>
      <value value="gordelroos"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="rotavirus vaccine, NOS"/>
    </extension>
    <code value="122"/>
    <display value="rotavirus, NOS1"/>
    <designation>
      <language value="nl"/>
      <value value="rotavirus, niet anders gespecificeerd1"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="tetanus immune globulin"/>
    </extension>
    <code value="13"/>
    <display value="TIG"/>
    <designation>
      <language value="nl"/>
      <value value="TIG"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="immune globulin, NOS"/>
    </extension>
    <code value="14"/>
    <display value="IG, NOS"/>
    <designation>
      <language value="nl"/>
      <value value="IG, niet anders gespecificeerd"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="influenza virus vaccine, split virus (incl. purified surface antigen)"/>
    </extension>
    <code value="15"/>
    <display value="influenza, split (incl. purified surface antigen)"/>
    <designation>
      <language value="nl"/>
      <value value="influenza, gesplitst (incl. gezuiverd oppervlakte antigen)"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="influenza virus vaccine, whole virus"/>
    </extension>
    <code value="16"/>
    <display value="influenza, whole"/>
    <designation>
      <language value="nl"/>
      <value value="influenza, geheel"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="Haemophilus influenzae type b vaccine, conjugate NOS"/>
    </extension>
    <code value="17"/>
    <display value="Hib, NOS"/>
    <designation>
      <language value="nl"/>
      <value value="Hib, niet anders gespecificeerd"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="rabies vaccine, for intramuscular injection"/>
    </extension>
    <code value="18"/>
    <display value="rabies, intramuscular injection"/>
    <designation>
      <language value="nl"/>
      <value value="hondsdolheid, intramusculaire injectie"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="Bacillus Calmette-Guerin vaccine"/>
    </extension>
    <code value="19"/>
    <display value="BCG"/>
    <designation>
      <language value="nl"/>
      <value value="BCG"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="diphtheria, tetanus toxoids and acellular pertussis vaccine"/>
    </extension>
    <code value="20"/>
    <display value="DTaP"/>
    <designation>
      <language value="nl"/>
      <value value="DaKT -difterie-acellulaire kinkhoest-tetanus"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="varicella virus vaccine"/>
    </extension>
    <code value="21"/>
    <display value="varicella"/>
    <designation>
      <language value="nl"/>
      <value value="varicella"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="DTP-Haemophilus influenzae type b conjugate vaccine"/>
    </extension>
    <code value="22"/>
    <display value="DTP-Hib"/>
    <designation>
      <language value="nl"/>
      <value value="DKT-Hib"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="plague vaccine"/>
    </extension>
    <code value="23"/>
    <display value="plague"/>
    <designation>
      <language value="nl"/>
      <value value="pest"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="anthrax vaccine"/>
    </extension>
    <code value="24"/>
    <display value="anthrax"/>
    <designation>
      <language value="nl"/>
      <value value="miltvuur"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="typhoid vaccine, live, oral"/>
    </extension>
    <code value="25"/>
    <display value="typhoid, oral"/>
    <designation>
      <language value="nl"/>
      <value value="tyfus, oral"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="cholera vaccine"/>
    </extension>
    <code value="26"/>
    <display value="cholera"/>
    <designation>
      <language value="nl"/>
      <value value="cholera"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="botulinum antitoxin"/>
    </extension>
    <code value="27"/>
    <display value="botulinum antitoxin"/>
    <designation>
      <language value="nl"/>
      <value value="botulisme antitoxine"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="diphtheria and tetanus toxoids, adsorbed for pediatric use"/>
    </extension>
    <code value="28"/>
    <display value="DT (pediatric)"/>
    <designation>
      <language value="nl"/>
      <value value="DT - difterie-tetanus (pediatrie)"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="cytomegalovirus immune globulin, intravenous"/>
    </extension>
    <code value="29"/>
    <display value="CMVIG"/>
    <designation>
      <language value="nl"/>
      <value value="CMVIG"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="hepatitis B immune globulin"/>
    </extension>
    <code value="30"/>
    <display value="HBIG"/>
    <designation>
      <language value="nl"/>
      <value value="HBIG"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="hepatitis A vaccine, pediatric dosage, NOS"/>
    </extension>
    <code value="31"/>
    <display value="Hep A, pediatric, NOS"/>
    <designation>
      <language value="nl"/>
      <value value="Hep A, pediatrie, niet anders gespecificeerd"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="meningococcal polysaccharide vaccine (MPSV4)"/>
    </extension>
    <code value="32"/>
    <display value="meningococcal"/>
    <designation>
      <language value="nl"/>
      <value value="meningokokken"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="pneumococcal polysaccharide vaccine"/>
    </extension>
    <code value="33"/>
    <display value="pneumococcal"/>
    <designation>
      <language value="nl"/>
      <value value="pneumokokken"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="rabies immune globulin"/>
    </extension>
    <code value="34"/>
    <display value="RIG"/>
    <designation>
      <language value="nl"/>
      <value value="hondsdolheid immunoglobuline"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="tetanus toxoid, adsorbed"/>
    </extension>
    <code value="35"/>
    <display value="tetanus toxoid"/>
    <designation>
      <language value="nl"/>
      <value value="tetanus toxoïde"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="varicella zoster immune globulin"/>
    </extension>
    <code value="36"/>
    <display value="VZIG"/>
    <designation>
      <language value="nl"/>
      <value value="VZIG"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="yellow fever vaccine"/>
    </extension>
    <code value="37"/>
    <display value="yellow fever"/>
    <designation>
      <language value="nl"/>
      <value value="gele koorts"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="rubella and mumps virus vaccine"/>
    </extension>
    <code value="38"/>
    <display value="rubella/mumps"/>
    <designation>
      <language value="nl"/>
      <value value="rodehond/bof"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="Japanese encephalitis vaccine"/>
    </extension>
    <code value="39"/>
    <display value="Japanese encephalitis"/>
    <designation>
      <language value="nl"/>
      <value value="Japanse encefalitis"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="rabies vaccine, for intradermal injection"/>
    </extension>
    <code value="40"/>
    <display value="rabies, intradermal injection"/>
    <designation>
      <language value="nl"/>
      <value value="hondsdolheid, intradermale injectie"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="typhoid vaccine, parenteral, other than acetone-killed, dried"/>
    </extension>
    <code value="41"/>
    <display value="typhoid, parenteral"/>
    <designation>
      <language value="nl"/>
      <value value="tyfus, parenteraal"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="hepatitis B vaccine, adolescent/high risk infant dosage"/>
    </extension>
    <code value="42"/>
    <display value="Hep B, adolescent/high risk infant2"/>
    <designation>
      <language value="nl"/>
      <value value="Hep B, adolescent/hoogrisico zuigeling2"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="hepatitis B vaccine, adult dosage"/>
    </extension>
    <code value="43"/>
    <display value="Hep B, adult4"/>
    <designation>
      <language value="nl"/>
      <value value="Hep B, volwassen4"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="hepatitis B vaccine, dialysis patient dosage"/>
    </extension>
    <code value="44"/>
    <display value="Hep B, dialysis"/>
    <designation>
      <language value="nl"/>
      <value value="Hep B, dialyse"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="hepatitis B vaccine, NOS"/>
    </extension>
    <code value="45"/>
    <display value="Hep B, NOS"/>
    <designation>
      <language value="nl"/>
      <value value="Hep B, niet anders gespecificeerd"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="Haemophilus influenzae type b vaccine, PRP-D conjugate"/>
    </extension>
    <code value="46"/>
    <display value="Hib (PRP-D)"/>
    <designation>
      <language value="nl"/>
      <value value="Hib (PRP-D)"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="Haemophilus influenzae type b vaccine, HbOC conjugate"/>
    </extension>
    <code value="47"/>
    <display value="Hib (HbOC)"/>
    <designation>
      <language value="nl"/>
      <value value="Hib (HbOC)"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="Haemophilus influenzae type b vaccine, PRP-T conjugate"/>
    </extension>
    <code value="48"/>
    <display value="Hib (PRP-T)"/>
    <designation>
      <language value="nl"/>
      <value value="Hib (PRP-T)"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="Haemophilus influenzae type b vaccine, PRP-OMP conjugate"/>
    </extension>
    <code value="49"/>
    <display value="Hib (PRP-OMP)"/>
    <designation>
      <language value="nl"/>
      <value value="Hib (PRP-OMP)"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="DTaP-Haemophilus influenzae type b conjugate vaccine"/>
    </extension>
    <code value="50"/>
    <display value="DTaP-Hib"/>
    <designation>
      <language value="nl"/>
      <value value="DaKT-Hib"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="Haemophilus influenzae type b conjugate and Hepatitis B vaccine"/>
    </extension>
    <code value="51"/>
    <display value="Hib-Hep B"/>
    <designation>
      <language value="nl"/>
      <value value="Hib-Hep B"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="hepatitis A vaccine, adult dosage"/>
    </extension>
    <code value="52"/>
    <display value="Hep A, adult"/>
    <designation>
      <language value="nl"/>
      <value value="Hep A, volwassene"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)"/>
    </extension>
    <code value="53"/>
    <display value="typhoid, parenteral, AKD (U.S. military)"/>
    <designation>
      <language value="nl"/>
      <value value="tyfus, parenteraal, AKD (Amerikaanse leger)"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="adenovirus vaccine, type 4, live, oral"/>
    </extension>
    <code value="54"/>
    <display value="adenovirus, type 4"/>
    <designation>
      <language value="nl"/>
      <value value="adenovirus, type 4"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="adenovirus vaccine, type 7, live, oral"/>
    </extension>
    <code value="55"/>
    <display value="adenovirus, type 7"/>
    <designation>
      <language value="nl"/>
      <value value="adenovirus, type 7"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="dengue fever vaccine"/>
    </extension>
    <code value="56"/>
    <display value="dengue fever"/>
    <designation>
      <language value="nl"/>
      <value value="knokkelkoorts"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="hantavirus vaccine"/>
    </extension>
    <code value="57"/>
    <display value="hantavirus"/>
    <designation>
      <language value="nl"/>
      <value value="hantavirus"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="hepatitis C vaccine"/>
    </extension>
    <code value="58"/>
    <display value="Hep C"/>
    <designation>
      <language value="nl"/>
      <value value="Hep C"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="hepatitis E vaccine"/>
    </extension>
    <code value="59"/>
    <display value="Hep E"/>
    <designation>
      <language value="nl"/>
      <value value="Hep E"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="herpes simplex virus, type 2 vaccine"/>
    </extension>
    <code value="60"/>
    <display value="herpes simplex 2"/>
    <designation>
      <language value="nl"/>
      <value value="herpes simplex 2"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="human immunodeficiency virus vaccine"/>
    </extension>
    <code value="61"/>
    <display value="HIV"/>
    <designation>
      <language value="nl"/>
      <value value="HIV"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="human papilloma virus vaccine, quadrivalent"/>
    </extension>
    <code value="62"/>
    <display value="HPV, quadrivalent"/>
    <designation>
      <language value="nl"/>
      <value value="HPV, quadrivalent"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="Junin virus vaccine"/>
    </extension>
    <code value="63"/>
    <display value="Junin virus"/>
    <designation>
      <language value="nl"/>
      <value value="Junín virus"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="leishmaniasis vaccine"/>
    </extension>
    <code value="64"/>
    <display value="leishmaniasis"/>
    <designation>
      <language value="nl"/>
      <value value="leishmaniase"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="leprosy vaccine"/>
    </extension>
    <code value="65"/>
    <display value="leprosy"/>
    <designation>
      <language value="nl"/>
      <value value="lepra"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="Lyme disease vaccine"/>
    </extension>
    <code value="66"/>
    <display value="Lyme disease"/>
    <designation>
      <language value="nl"/>
      <value value="ziekte van Lyme"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="malaria vaccine"/>
    </extension>
    <code value="67"/>
    <display value="malaria"/>
    <designation>
      <language value="nl"/>
      <value value="malaria"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="melanoma vaccine"/>
    </extension>
    <code value="68"/>
    <display value="melanoma"/>
    <designation>
      <language value="nl"/>
      <value value="melanoom"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="parainfluenza-3 virus vaccine"/>
    </extension>
    <code value="69"/>
    <display value="parainfluenza-3"/>
    <designation>
      <language value="nl"/>
      <value value="parainfluenza-3"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="Q fever vaccine"/>
    </extension>
    <code value="70"/>
    <display value="Q fever"/>
    <designation>
      <language value="nl"/>
      <value value="Q-koorts"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="respiratory syncytial virus immune globulin, intravenous"/>
    </extension>
    <code value="71"/>
    <display value="RSV-IGIV"/>
    <designation>
      <language value="nl"/>
      <value value="RSV-IGIV"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="rheumatic fever vaccine"/>
    </extension>
    <code value="72"/>
    <display value="rheumatic fever"/>
    <designation>
      <language value="nl"/>
      <value value="reumatische koorts"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="Rift Valley fever vaccine"/>
    </extension>
    <code value="73"/>
    <display value="Rift Valley fever"/>
    <designation>
      <language value="nl"/>
      <value value="Riftdalkoorts"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="rotavirus, live, tetravalent vaccine"/>
    </extension>
    <code value="74"/>
    <display value="rotavirus, tetravalent"/>
    <designation>
      <language value="nl"/>
      <value value="rotavirus, tetravalent"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="vaccinia (smallpox) vaccine"/>
    </extension>
    <code value="75"/>
    <display value="vaccinia (smallpox)"/>
    <designation>
      <language value="nl"/>
      <value value="vaccinia (pokken)"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="Staphylococcus bacteriophage lysate"/>
    </extension>
    <code value="76"/>
    <display value="Staphylococcus bacterio lysate"/>
    <designation>
      <language value="nl"/>
      <value value="Staphylococcus bacterio lysate"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="tick-borne encephalitis vaccine"/>
    </extension>
    <code value="77"/>
    <display value="tick-borne encephalitis"/>
    <designation>
      <language value="nl"/>
      <value value="frühsommer-meningoenzephalitis vaccin"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="tularemia vaccine"/>
    </extension>
    <code value="78"/>
    <display value="tularemia vaccine"/>
    <designation>
      <language value="nl"/>
      <value value="tularemia vaccin"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="vaccinia immune globulin"/>
    </extension>
    <code value="79"/>
    <display value="vaccinia immune globulin"/>
    <designation>
      <language value="nl"/>
      <value value="vaccinia immunoglobuline"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="Venezuelan equine encephalitis, live, attenuated"/>
    </extension>
    <code value="80"/>
    <display value="VEE, live"/>
    <designation>
      <language value="nl"/>
      <value value="VEE, levend"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="Venezuelan equine encephalitis, inactivated"/>
    </extension>
    <code value="81"/>
    <display value="VEE, inactivated"/>
    <designation>
      <language value="nl"/>
      <value value="VEE, inactief"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="adenovirus vaccine, NOS"/>
    </extension>
    <code value="82"/>
    <display value="adenovirus, NOS1"/>
    <designation>
      <language value="nl"/>
      <value value="adenovirus, niet anders gespecificeerd1"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule"/>
    </extension>
    <code value="83"/>
    <display value="Hep A, ped/adol, 2 dose"/>
    <designation>
      <language value="nl"/>
      <value value="Hep A, ped/adol, 2 dosis"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule"/>
    </extension>
    <code value="84"/>
    <display value="Hep A, ped/adol, 3 dose"/>
    <designation>
      <language value="nl"/>
      <value value="Hep A, ped/adol, 3 dosis"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="hepatitis A vaccine, NOS"/>
    </extension>
    <code value="85"/>
    <display value="Hep A, NOS"/>
    <designation>
      <language value="nl"/>
      <value value="Hep A, niet anders gespecificeerd"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="immune globulin, intramuscular"/>
    </extension>
    <code value="86"/>
    <display value="IG"/>
    <designation>
      <language value="nl"/>
      <value value="IG"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="immune globulin, intravenous"/>
    </extension>
    <code value="87"/>
    <display value="IGIV"/>
    <designation>
      <language value="nl"/>
      <value value="IGIV"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="influenza virus vaccine, NOS"/>
    </extension>
    <code value="88"/>
    <display value="influenza, NOS"/>
    <designation>
      <language value="nl"/>
      <value value="influenza, niet anders gespecificeerd"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="poliovirus vaccine, NOS"/>
    </extension>
    <code value="89"/>
    <display value="polio, NOS"/>
    <designation>
      <language value="nl"/>
      <value value="polio, niet anders gespecificeerd"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="rabies vaccine, NOS"/>
    </extension>
    <code value="90"/>
    <display value="rabies, NOS"/>
    <designation>
      <language value="nl"/>
      <value value="hondsdolheid, niet anders gespecificeerd"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="typhoid vaccine, NOS"/>
    </extension>
    <code value="91"/>
    <display value="typhoid, NOS"/>
    <designation>
      <language value="nl"/>
      <value value="tyfus, niet anders gespecificeerd"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="Venezuelan equine encephalitis vaccine, NOS"/>
    </extension>
    <code value="92"/>
    <display value="VEE, NOS"/>
    <designation>
      <language value="nl"/>
      <value value="VEE, niet anders gespecificeerd"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular"/>
    </extension>
    <code value="93"/>
    <display value="RSV-MAb"/>
    <designation>
      <language value="nl"/>
      <value value="RSV-MAb"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="measles, mumps, rubella, and varicella virus vaccine"/>
    </extension>
    <code value="94"/>
    <display value="MMRV"/>
    <designation>
      <language value="nl"/>
      <value value="BMRV - bof, mazelen, rodehond en varicella"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="tuberculin skin test; old tuberculin, multipuncture device"/>
    </extension>
    <code value="95"/>
    <display value="TST-OT tine test"/>
    <designation>
      <language value="nl"/>
      <value value="TST-OT tine test"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="tuberculin skin test; purified protein derivative solution, intradermal"/>
    </extension>
    <code value="96"/>
    <display value="TST-PPD intradermal"/>
    <designation>
      <language value="nl"/>
      <value value="TST-PPD intradermal"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="tuberculin skin test; purified protein derivative, multipuncture device"/>
    </extension>
    <code value="97"/>
    <display value="TST-PPD tine test"/>
    <designation>
      <language value="nl"/>
      <value value="TST-PPD tine test"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="tuberculin skin test; NOS"/>
    </extension>
    <code value="98"/>
    <display value="TST, NOS"/>
    <designation>
      <language value="nl"/>
      <value value="TST, niet anders gespecificeerd"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="RESERVED - do not use"/>
    </extension>
    <code value="99"/>
    <display value="RESERVED - do not use3"/>
    <designation>
      <language value="nl"/>
      <value value="GERESERVEERD - niet gebruiken3"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="no vaccine administered"/>
    </extension>
    <code value="998"/>
    <display value="no vaccine administered5"/>
    <designation>
      <language value="nl"/>
      <value value="geen vaccin toegediend5"/>
    </designation>
  </concept>
  <concept>
    <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments">
      <valueString value="unknown vaccine or immune globulin"/>
    </extension>
    <code value="999"/>
    <display value="unknown"/>
    <designation>
      <language value="nl"/>
      <value value="onbekend"/>
    </designation>
  </concept>
</CodeSystem>

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.